GW9662
SIGMA/M6191 - >98% (HPLC)
Synonym: 2-
CAS Number: 22978-25-2
Empirical Formula (Hill Notation): C13H9ClN2O3
Molecular Weight: 276.68
MDL Number: MFCD01215270
Linear Formula: C13H9ClN2O3
Product Type: Chemical
| assay | >98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C13H9ClN2O3/c14-12-7-6 |
| InChI key | DNTSIBUQMRRYIU-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | [O-][N+](=O)c1ccc(Cl)c(c1 |
| solubility | DMSO: 26 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Application: | GW9662 has been used as a peroxisome proliferator activated receptor γ (PPARγ) antagonist in human pluripotent stem cells, in phenylephrine stimulated cardiomyocytes and to inhibit the protective effect of telmisartan pheochromocytoma, PC12 cells. |
| Biochem/physiol Actions: | GW9662 (2-chloro-5-nitrobenzanil |
| Biochem/physiol Actions: | GW9662 is an irreversible PPARγ antagonist. GW9662 inhibits connective tissue growth factor and activation of CD36 by IL-4. |
| Biochem/physiol Actions: | GW9662 is an irreversible PPARγ antagonist; inhibits connective tissue growth factor, and activation of CD36 by IL-4. |
| Features and Benefits: | This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Legal Information: | Sold for research purposes only, under agreement from GlaxoSmithKline |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36-43 |
| Safety Statements | 26-36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | >98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |

